Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michele Lodde

Showing results (31-40 of 65) with videos related to

Pageof 7
Sort By:
International Braz J Urol : Official Journal of the Brazilian Society of Urology|November 26, 2013
Comparison of radical cystectomy with conservative treatment in geriatric (≥80) patients with muscle-invasive bladder cancerThomas Martini, Roman Mayr, Clemens Wehrberger, et al.
Urology|February 1, 2003
Role of uCyt+ in the detection and surveillance of urothelial carcinomaMichele Lodde, Christine Mian, Giovanni Negri, et al.
The Prostate|March 17, 2006
Molecular biological analysis of the heterogeneous prostate cancer group Gleason score 7Christine Mian, Michele Lodde, Evi Comploj, et al.
European Urology|June 1, 2005
Four years experience in bladder preserving management for muscle invasive bladder cancerMichele Lodde, Salvatore Palermo, Evi Comploj, et al.
The Journal of Pathology|September 21, 2004
The androgen receptor co-activator CBP is up-regulated following androgen withdrawal and is highly expressed in advanced prostate cancerBarbara Comuzzi, Constanze Nemes, Stefan Schmidt, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|June 21, 2014
Recurrence and progression in patients with non-muscle invasive bladder cancer: prognostic models including multicolor fluorescence in situ hybridization molecular gradingMichele Lodde, Christine Mian, Roman Mayr, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|June 21, 2014
Response to editorial comment from Dr Todenhöfer and Dr Schwentner to recurrence and progression in patients with non-muscle invasive bladder cancer: prognostic models including multicolor fluorescence in situ hybridization molecular gradingMichele Lodde, Christine Mian, Roman Mayr, et al.
World Journal of Urology|October 30, 2013
Perforation during TUR of bladder tumours influences the natural history of superficial bladder cancerEvi Comploj, Christopher B Dechet, Michael Mian, et al.
Anticancer Research|June 13, 2014
Long-term follow-up of intermediate-risk non-muscle invasive bladder cancer sub-classified by multi-coloured FISHChristine Mian, Evi Comploj, Elisabeth Resnyak, et al.
Clinical Nutrition ESPEN|January 22, 2022
Effects of omega-3 fatty acids supplementation on perioperative blood loss and complications after radical prostatectomySamuel Fradet, Jean-François Pelletier, Narcisse Singbo, et al.
Pageof 7

Showing results (31-40 of 65) with videos related to

Sort By:
Pageof 7
International Braz J Urol : Official Journal of the Brazilian Society of Urology|November 26, 2013
Comparison of radical cystectomy with conservative treatment in geriatric (≥80) patients with muscle-invasive bladder cancerThomas Martini, Roman Mayr, Clemens Wehrberger, et al.
Urology|February 1, 2003
Role of uCyt+ in the detection and surveillance of urothelial carcinomaMichele Lodde, Christine Mian, Giovanni Negri, et al.
The Prostate|March 17, 2006
Molecular biological analysis of the heterogeneous prostate cancer group Gleason score 7Christine Mian, Michele Lodde, Evi Comploj, et al.
European Urology|June 1, 2005
Four years experience in bladder preserving management for muscle invasive bladder cancerMichele Lodde, Salvatore Palermo, Evi Comploj, et al.
The Journal of Pathology|September 21, 2004
The androgen receptor co-activator CBP is up-regulated following androgen withdrawal and is highly expressed in advanced prostate cancerBarbara Comuzzi, Constanze Nemes, Stefan Schmidt, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|June 21, 2014
Recurrence and progression in patients with non-muscle invasive bladder cancer: prognostic models including multicolor fluorescence in situ hybridization molecular gradingMichele Lodde, Christine Mian, Roman Mayr, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|June 21, 2014
Response to editorial comment from Dr Todenhöfer and Dr Schwentner to recurrence and progression in patients with non-muscle invasive bladder cancer: prognostic models including multicolor fluorescence in situ hybridization molecular gradingMichele Lodde, Christine Mian, Roman Mayr, et al.
World Journal of Urology|October 30, 2013
Perforation during TUR of bladder tumours influences the natural history of superficial bladder cancerEvi Comploj, Christopher B Dechet, Michael Mian, et al.
Anticancer Research|June 13, 2014
Long-term follow-up of intermediate-risk non-muscle invasive bladder cancer sub-classified by multi-coloured FISHChristine Mian, Evi Comploj, Elisabeth Resnyak, et al.
Clinical Nutrition ESPEN|January 22, 2022
Effects of omega-3 fatty acids supplementation on perioperative blood loss and complications after radical prostatectomySamuel Fradet, Jean-François Pelletier, Narcisse Singbo, et al.
Pageof 7